Abstract
The coexistence of hyperparathyroidism complicating thyrotoxicosis is quite rare. We report the case of one patient who presented with thyrotoxicosis, (total thyroxine of 15.1 µg/dl (5–13), free thyroxine index of 18 (4–15) and triiodothyronine by RIA of 305 ng/dl (70–230) and asymptomatic hypercalcemia of 15 mg/dl (8.5–10.6), who was also initially noted to have an elevated (C-terminal) serum immunoreactive parathyroid hormone (iPTH) level of 8,800 pg/ml (50–340). With propylthiouracil and propranolol, however, this patient became normocalcemic with a decrease in iPTH values to 714 pg/ml. As the patient was tapered from medication, after being rendered euthyroid, a recurrence of hypercalcemia with rising iPTH levels occurred. PTH levels should be helpful in defining coexisting hyperparathyroidism in patients with thyrotoxicosis since in the latter iPTH is usually suppressed. Our findings support the recommendation that in patients suspected of having both hyperparathyroidism and hyperthyroidism, a diagnosis of the former can only be made with certainty after the patient has been rendered euthyroid with persistently elevated serum calcium and iPTH levels. While there are no clinical features which permit the easy identification of patients who present with dual lesions, the determination of iPTH values may be the most consistently helpful test initially, whereas other parameters such as vitamin D, serum phosphate are less reliable.
Similar content being viewed by others
References
Aanderud S., Bassoe H. Thyrotoxic hypercalcemia treated with corticosteroids. Acta Med. Scand. 207: 499, 1980.
Baxter J.D., Bondy P. Hypercalcemia of thyrotoxicosis. Ann. Int. Med. 65: 429, 1966.
Gordon D., Suvanich S., Erviti V., Schwartz M., Martinez C. The serum calcium level and its significance In hyperthyroidism: A prospective study. Am. J. Med. Sci. 268: 31, 1974.
Moskilde L., Meisen T., Bagga J.P., Myhre-Jensen O., Sorensen N.S. Bone changes in hyperthyroidism: Interrelationship between bone morphometry thyroid function and calcium phosphorus metabolism. Acta. Endocrinol. (Copenh.) 85: 515, 1977.
Barsotti M., Targovnik J., Verso T. Thyrotoxicosis, hypercalcemia, and secondary hyperparathyroidism. Arch. Intern Med. 139: 661, 1979.
Bergdahl L. Hyperparathyroidism in thyrotoxicosis. Am. J. Surg. 133: 206, 1977.
Arem R., Lim-Abrahan M., Mallette L. Concomitant graves disease and primary hyperparathyroidism: Influence of hyperthyroidism on serum calcium and parathyroid hormone. Am. J. Med. 80: 693, 1986.
Ackerman N., Arribas R. Hyperparathyroidism with co-existing hyperthyroidism. Am J. Surg. 132: 660, 1976.
Twycross R.G., Marks V. Symptomatic hypercalcemia in thyrotoxi-cosis. Br. Med. J. 2: 701, 1970.
Zwillich C.W., Matthay M, Potts D.E. Thyrotoxicosis: comparison of effects of thyroid ablation and beta adrenergic blockade on metabolic rate and ventilatory control. J. Clin. Endocrinol. Metab. 46: 491, 1978.
Rude R.K., Oldham S.B., Singer F.R., Nicoloff J.T. Treatment of thyrotoxic hypercalcemia with propranolol. N. Engl. J. Med. 294: 431, 1976.
Shahshahani M., Palmieri G. Oral propranolol in hypercalcemia associated with apathetic thyrotoxicosis. Am. J. Med. Sci. 275: 199, 1978.
Aub J.C., Bauer W., Heath C., Ropes M. Studies of calcium and phosphorus metabolism. III. The effects of thyroid hormone and thyroid disease. J.Clin. Invest. 7: 97, 1929.
Haldimann B., Kapstein E.M., Singer F.R., Nicoloff J.T., Massry S.G. Intestinal calcium absorption in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 51: 995, 1980.
Szabo Z.S., Ritzl F. Hypercalcemia in hyperthyroidism: Role of age and goiter type. Klin. Wochenschr. 59: 275, 1981.
Askenasi R., Demeester-Mirkine N. Urinary excretion of hydroxylysyl glycosides and thyroid function. J. Clin. Endocrinol. Metab. 40: 342, 1975.
Katz A.I., Emmanuel D.S., Lindheimer M.D. Thyroid hormone and the kidney. Nephron 15: 223, 1975.
Breuer R.I., McPherson H. Hypercalcemia in concurrent hyperthyroidism and hyperparathyroidism. Arch. Intern Med. 118: 310, 1966.
Ahuja M.M.S., Chopra I.J. Co-existent hyperthyroidism and hyperparathyroidism. Metabolism 17: 854, 1968.
Maxon H.R., Apple D., Goldsmith R. Hypercalcemia in thyrotoxicosis. Surg. Gynecol., Obtset. 147: 694, 1978.
Fisher J.A., Blum J.W., Binswanger U. Acute parathyroid hormone response to epi-nephrine in vitro. J. Clin. Invest. 52: 2434, 1973.
Metz S.A., Deftos L.J., Baylink D.J. Neuroendocrine modulation of calcitonin and parathyroid hormone in man. J. Clin. Endocrinol. Metab. 47: 151, 1978.
Yasumura S., Burk M., Chausmer A., Mittleman R., Wallach S. Thyroidal content of thyrocalcitonin in hypothyroid and hyperthyroid rats. Endocrinology 81: 256, 1967.
Piccione W. Jr., Selenkow H.A., Cody B. Management of problems in co-existing parathyroid crisis and florid thyrotoxicosis. Surgery 9: 1009, 1984.
Feely J. Propranolol and the hypercalcemia of thyrotoxicosis. Acta. Endocrinol. (Copenh.) 98: 528, 1981.
Buckle R.M., Mason A.M.S., Middleton J.E. Thyrotoxic hypercalcemia treated with porcine Calcitonin. Lancet 1: 1128, 1969.
Manderlier T.H., Bergans. A., Brauman J, Brauman H, Corvilain J. Etude de la fonction parathyroidienne dans l’hyperthyroidie. Ann. Endocrinol. (Paris) 35: 185, 1974 (Abstract).
Burman K.D., Monchik J.M., Earll J.M. Ionized and total serum calcium and parathyroid hormone In hyperthyroidism. Ann. Intern Med. 84: 668, 1976.
Chase L.R., Aurbach G.D. The effect of parathyroid hormone on the concentration of adenosine 3′5′ mono-phosphate in skeletal tissue in vitro. J. Biol. Chem. 245: 1520, 1970.
Frietag J., Martin K.J., Hruska K.A. Impaired parathyroid hormone metabolism in patient with chronic renal failure. N. Engl. J. Med. 298: 29, 1978.
Mallette L.E., Tuma S.N., Berger R.E., Kirkland J.L. Radioimmunoassay for the mid-region of human parathyroid hormone using a homologous antiserum with a carboxyterminal fragment of bovine parathyroid hormone as radioligand. J. Clin. Endocrinol. Metab. 54: 1017, 1982.
Lamb H.C., Ho L.T., Tang K.T., Ching K.N. Primary hyperparathyroidism and coexisting hyperthyroidism: review of the literature. Chin. Med. J. 43: 105, 1989.
Rao K.M. Concurrent hyperthyroidism and hyperparathyroidism. Br. J. Surg. 57: 868, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGowan, D.M., Vaswani, A.N. & Shperling, I. Coexisting hyperparathyroidism with thyrotoxicosis. J Endocrinol Invest 14, 305–310 (1991). https://doi.org/10.1007/BF03346819
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346819